Oleocanthal Ameliorates Amyloid-β Oligomers Toxicity on Astrocytes and Neuronal Cells: In-vitro Studies

Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes....

Full description

Saved in:
Bibliographic Details
Published inNeuroscience Vol. 352; pp. 204 - 215
Main Authors Batarseh, Yazan S, Mohamed, Loqman A, Al Rihani, Sweilem B, Mousa, Youssef M, Siddique, Abu Bakar, El Sayed, Khalid A, Kaddoumi, Amal
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 03.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes.
AbstractList Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves cognitive function in experimental animal models, suggesting it's potential to protect and reduce the risk of developing Alzheimer's disease (AD). Available studies have linked this beneficial effect to oleocanthal, one of the active components in EVOO. The effect of oleocanthal against AD pathology has been linked to its ability to attenuate Aβ and tau aggregation in vitro, and enhance Aβ clearance from the brains of wild-type and AD transgenic mice in vivo. However, the ability of oleocanthal to alter the toxic effect of Aβ on brain parenchymal cells is unknown. In the current study, we investigated oleocanthal effect on modulating Aβ oligomers (Aβo) pathological events in neurons and astrocytes. Our findings demonstrated oleocanthal prevented Aβo-induced synaptic proteins, SNAP-25 and PSD-95, down-regulation in neurons, and attenuated Aβo-induced inflammation, glutamine transporter (GLT1) and glucose transporter (GLUT1) down-regulation in astrocytes. Aβo-induced inflammation was characterized by interleukin-6 (IL-6) increase and glial fibrillary acidic protein (GFAP) upregulation that were reduced by oleocanthal. In conclusion, this study provides further evidence to support the protective effect of EVOO-derived phenolic secoiridoid oleocanthal against AD pathology.
Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and inflammation associated with Aβ oligomers exposure. • The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes.
•Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in vitro.•Oleocanthal reduced astrocyte activation and inflammation associated with Aβ oligomer exposure.•The neuroprotective effect of oleocanthal could be direct and not mediated by astrocytes. Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves cognitive function in experimental animal models, suggesting it’s potential to protect and reduce the risk of developing Alzheimer’s disease (AD). Available studies have linked this beneficial effect to oleocanthal, one of the active components in EVOO. The effect of oleocanthal against AD pathology has been linked to its ability to attenuate Aβ and tau aggregation in vitro, and enhance Aβ clearance from the brains of wild-type and AD transgenic mice in vivo. However, the ability of oleocanthal to alter the toxic effect of Aβ on brain parenchymal cells is unknown. In the current study, we investigated oleocanthal effect on modulating Aβ oligomers (Aβo) pathological events in neurons and astrocytes. Our findings demonstrated oleocanthal prevented Aβo-induced synaptic proteins, SNAP-25 and PSD-95, down-regulation in neurons, and attenuated Aβo-induced inflammation, glutamine transporter (GLT1) and glucose transporter (GLUT1) down-regulation in astrocytes. Aβo-induced inflammation was characterized by interleukin-6 (IL-6) increase and glial fibrillary acidic protein (GFAP) upregulation that were reduced by oleocanthal. In conclusion, this study provides further evidence to support the protective effect of EVOO-derived phenolic secoiridoid oleocanthal against AD pathology.
Author Batarseh, Yazan S
Siddique, Abu Bakar
Mohamed, Loqman A
Mousa, Youssef M
El Sayed, Khalid A
Kaddoumi, Amal
Al Rihani, Sweilem B
Author_xml – sequence: 1
  fullname: Batarseh, Yazan S
– sequence: 2
  fullname: Mohamed, Loqman A
– sequence: 3
  fullname: Al Rihani, Sweilem B
– sequence: 4
  fullname: Mousa, Youssef M
– sequence: 5
  fullname: Siddique, Abu Bakar
– sequence: 6
  fullname: El Sayed, Khalid A
– sequence: 7
  fullname: Kaddoumi, Amal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28392295$$D View this record in MEDLINE/PubMed
BookMark eNqNks1OGzEUha0KVALtK1Sj7mfw7_ywQIrSFpBQs4CuLce-Q5w6NrInUee1-iB9JjwKRbQrvLmWfM65V5_vKTrywQNCnwmuCCb1-abysIshaQteQ0UxaSrMKiy6d2hG2oaVjeD8CM0ww3XJBaUn6DSlDc5HcPYendCWdZR2YobWSwdBKz-slSvmW3A2RDVAyvfRBWvKP7-LpbMPYQsxFffhl9V2GIvgi3kaYtDjpFXeFN-nkXwOWYBz6aK48eXeZkVxN-yMhfQBHffKJfj4XM_Qj29f7xfX5e3y6mYxvy214HQoW4HbVvdU9H3XiVXLWM2VNoAV5ZipRgtcC7HqMaNNs-Kkq4HURhCuc2HasDN0ech93K22YDT4ISonH6PdqjjKoKz898XbtXwIeykE5nVX54CLQ4DOiFOE_sVLsJz4y418zV9O_CVmMvPP5k-vu79Y_wLPgi8HAWQGewtRPscYG0EP0gT7tj6X_8VoZ73Vyv2EEdIm7GL-iySJTFRieTdtwrQIpGGYMt6yJ0LJt-c
CitedBy_id crossref_primary_10_1016_j_jnutbio_2017_12_006
crossref_primary_10_1111_bcpt_14006
crossref_primary_10_1016_j_ctim_2018_12_003
crossref_primary_10_3390_ijms18112230
crossref_primary_10_3390_molecules24102001
crossref_primary_10_1186_s12868_019_0489_5
crossref_primary_10_1016_j_advms_2022_08_003
crossref_primary_10_1016_j_arcmed_2024_103039
crossref_primary_10_3390_nu13051702
crossref_primary_10_1007_s13668_018_0222_5
crossref_primary_10_3390_ijms21072501
crossref_primary_10_1016_j_ijpharm_2019_118596
crossref_primary_10_1021_acsptsci_0c00166
crossref_primary_10_3390_ijms20246303
crossref_primary_10_3390_foods7060090
crossref_primary_10_3390_molecules23040870
crossref_primary_10_1007_s12035_022_03042_8
crossref_primary_10_1016_j_arr_2024_102210
crossref_primary_10_1016_j_ejpn_2018_11_007
crossref_primary_10_3390_ijms19082329
crossref_primary_10_3390_pharmaceutics11100515
crossref_primary_10_1016_j_expneurol_2020_113248
crossref_primary_10_1038_s41598_021_01752_y
crossref_primary_10_3390_ijms25031914
crossref_primary_10_1016_j_neurol_2019_07_017
crossref_primary_10_3390_nu14142998
crossref_primary_10_1017_S095442242100041X
crossref_primary_10_3390_nu12020314
crossref_primary_10_1016_j_ejmech_2019_03_009
crossref_primary_10_3389_fnins_2022_952096
crossref_primary_10_3390_ijms242417323
crossref_primary_10_3389_fnagi_2020_617071
crossref_primary_10_1111_bph_14782
crossref_primary_10_3390_molecules28145592
crossref_primary_10_3390_ijms22147366
crossref_primary_10_3390_nu10050570
crossref_primary_10_1080_10408398_2019_1650715
crossref_primary_10_1021_acs_jafc_8b06723
crossref_primary_10_3233_JAD_190223
crossref_primary_10_1021_acs_jafc_8b00561
crossref_primary_10_1016_j_clineuro_2020_105727
crossref_primary_10_3390_cancers11050637
crossref_primary_10_3233_JAD_210595
Cites_doi 10.3390/ijms150712323
10.1038/srep38187
10.1186/1750-1326-9-48
10.1016/j.jalz.2015.02.003
10.1016/j.mrfmmm.2009.08.016
10.1523/JNEUROSCI.5274-12.2013
10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z
10.1016/j.ebiom.2016.03.035
10.1016/j.nbd.2008.02.012
10.1016/j.expneurol.2009.10.013
10.1002/glia.21004
10.1046/j.1471-4159.2000.0751076.x
10.3389/fnsyn.2016.00007
10.1021/cn400024q
10.1016/j.neuint.2016.05.009
10.3390/ijms17030338
10.1523/JNEUROSCI.6357-11.2012
10.1007/s00401-009-0522-3
10.1038/ncomms11761
10.1046/j.1469-7580.2002.00064.x
10.1111/j.1471-4159.2009.06224.x
10.1074/jbc.M407963200
10.1021/bi401606f
10.1016/j.lfs.2012.09.012
10.1038/437045a
10.1073/pnas.82.12.4245
10.3233/JAD-2010-1221
10.1074/jbc.M111.236257
10.4065/80.10.1326
10.1016/j.cbi.2005.10.088
10.2174/156720511794604543
10.1111/j.1742-4658.2010.07568.x
10.1016/j.bbr.2008.02.016
10.31887/DCNS.2009.11.3/mbelanger
10.1152/physrev.2001.81.2.741
10.1371/journal.pone.0155878
10.1007/s12640-014-9468-x
10.1212/WNL.0000000000000328
10.1016/j.taap.2009.07.018
10.1111/j.1471-4159.2007.04533.x
10.1016/j.tiv.2016.12.003
10.1080/15548627.2016.1159375
10.1016/j.neuropharm.2014.01.023
10.1038/nm838
10.1021/acschemneuro.5b00190
10.3389/fphys.2012.00269
10.1016/0006-291X(84)91209-9
10.1016/j.neuint.2016.04.010
ContentType Journal Article
Copyright IBRO
2017 IBRO
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: IBRO
– notice: 2017 IBRO
– notice: Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1016/j.neuroscience.2017.03.059
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1873-7544
EndPage 215
ExternalDocumentID 10_1016_j_neuroscience_2017_03_059
28392295
S0306452217302348
1_s2_0_S0306452217302348
Genre Journal Article
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P20 GM103424
– fundername: NINDS NIH HHS
  grantid: R15 NS091934
GroupedDBID -
08R
0R
1
1-
123
1B1
1P
1RT
1~.
1~5
29N
4.4
457
4G.
53G
55
5RE
5VS
7-5
71M
8P
9JM
AABNK
AACTN
AADPK
AAEDT
AAIAV
AAIKJ
AAKOC
AALMO
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
ABCQJ
ABFLS
ABFNM
ABFRF
ABLJU
ABMAC
ABPIF
ABPTK
ABQIS
ABTEW
ABWYI
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADALY
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AZFZN
BKOJK
BLXMC
CS3
DU5
DZ
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FO
G-
G-2
G-Q
GBLVA
GJ
HMQ
HVGLF
HZ
IHE
IPNFZ
J1W
K
KOM
L7B
M
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SSN
SSZ
T5K
UNMZH
WUQ
X
X7M
Z5R
ZGI
ZXP
---
--K
--M
-DZ
-~X
.1-
.FO
.~1
0R~
1P~
8P~
AAEDW
ABJNI
AXJTR
EFLBG
FYGXN
OP~
~G-
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
.55
.GJ
AAYXX
ADMUD
AFJKZ
CITATION
HZ~
YYP
5PM
ID FETCH-LOGICAL-c542t-85088cf25ff995b83364acde0a2403a7c50655bf03277b4196e16d514c16d3cd3
IEDL.DBID .~1
ISSN 0306-4522
IngestDate Tue Sep 17 20:58:18 EDT 2024
Thu Sep 26 17:04:19 EDT 2024
Sat Sep 28 08:39:01 EDT 2024
Fri Feb 23 02:29:42 EST 2024
Thu Aug 18 17:14:44 EDT 2022
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords APP
BBB
DMSO
Extra-virgin olive oil
Radioimmunoprecipitation assay
IDE
Blood brain barrier
Insulin-degrading enzyme
RIPA
Aβ oligomers
Interleukin-6

BSA
soluble APPβ
Apolipoprotein E
Phosphate buffer saline
ApoE
Amyloid-β
ABCA1
Glucose transporter
PBS
Bovine serum albumin
GLUT1
AD
GLT1
Alzheimer’s disease
Astrocytes
Neurons
Astrocytes conditioned media
Glial fibrillary acidic protein
Aβ monomer
Soluble APPα
Neuroinflammation
ACM
Oleocanthal
Amyloid precursor protein
IL-6
GFAP
sAPPα
EVOO
ATP-binding cassette transporter-A1
Glutamate transporter
Dimethyl sulfoxide
sAPPβ
Aβm
Aβo
neurons
oleocanthal
neuroinflammation
amyloid-β
astrocytes
Language English
License Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c542t-85088cf25ff995b83364acde0a2403a7c50655bf03277b4196e16d514c16d3cd3
OpenAccessLink https://europepmc.org/articles/pmc5504696?pdf=render
PMID 28392295
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5504696
crossref_primary_10_1016_j_neuroscience_2017_03_059
pubmed_primary_28392295
elsevier_sciencedirect_doi_10_1016_j_neuroscience_2017_03_059
elsevier_clinicalkeyesjournals_1_s2_0_S0306452217302348
PublicationCentury 2000
PublicationDate 2017-06-03
PublicationDateYYYYMMDD 2017-06-03
PublicationDate_xml – month: 06
  year: 2017
  text: 2017-06-03
  day: 03
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neuroscience
PublicationTitleAlternate Neuroscience
PublicationYear 2017
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Brown, Tamas, Reglodi, Tizabi (b0070) 2014; 26
Rimmele, Rosenberg (b0210) 2016; 98
Selkoe (b0235) 2008; 192
Danbolt, Furness, Zhou (b0085) 2016; 98
Lasagna-Reeves, Glabe, Kayed (b0135) 2011; 286
Scimemi, Meabon, Woltjer, Sullivan, Diamond, Cook (b0220) 2013; 33
Spuch, Ortolano, Navarro (b0250) 2012; 3
Scotece, Gomez, Conde, Lopez, Gomez-Reino, Lago, Smith, Gualillo (b0225) 2012; 91
Tu, Okamoto, Lipton, Xu (b0255) 2014; 9
Glenner, Wong (b0115) 1984; 122
Benarroch (b0060) 2014; 82
Cobos, del Pozo, Baeyens (b0080) 2007; 102
Li, Zhao, Gao, Wei, Yin, Lau, Chui, Yu (b0145) 2011; 8
Beauchamp, Keast, Morel, Lin, Pika, Han, Lee, Smith, Breslin (b0035) 2005; 437
Son, Cha, Choi, Kang, Choi, Lee, Park, Mook-Jung (b0245) 2016; 12
Pitt, Roth, Lacor, Smith, Blankenship, Velasco, De Felice, Breslin, Klein (b0195) 2009; 240
Nielsen, Mulder, Belien, Musters, Eikelenboom, Veerhuis (b0175) 2010; 58
Narayan, Holmstrom, Kim, Whitcomb, Wilson, St George-Hyslop, Wood, Dobson, Cho, Abramov, Klenerman (b0170) 2014; 53
Antonucci, Corradini, Fossati, Tomasoni, Menna, Matteoli (b0020) 2016; 8
Li, Sperry, Crowe, Trojanowski, Smith, Lee (b0150) 2009; 110
Fernandes, Emerick, Ferreira, Santos, Santos (b0105) 2017; 39
Siow, Xie, Choi, Tsim (b9000) 2005; 157–158
Selkoe (b0230) 2001; 81
Abbott (b0005) 2002; 200
Biedler, Roffler-Tarlov, Schachner, Freedman (b0065) 1978; 38
Murphy, LeVine (b0165) 2010; 19
Qosa, Batarseh, Mohyeldin, El Sayed, Keller, Kaddoumi (b0205) 2015; 6
Masters, Simms, Weinman, Multhaup, McDonald, Beyreuther (b0155) 1985; 82
Sakono, Zako (b0215) 2010; 277
Feng, Hu, Lu, Wang, Du (b0100) 2014; 7
Beglopoulos, Tulloch, Roe, Daumas, Ferrington, Watson, Fan, Hyman, Kelly, Bard, Morris (b0040) 2016; 7
Greber, Lubec, Cairns, Fountoulakis (b0120) 1999; 20
Parkinson, Keast (b0180) 2014; 15
Wyss-Coray, Loike, Brionne, Lu, Anankov, Yan, Silverstein, Husemann (b0265) 2003; 9
Sengupta, Nilson, Kayed (b0240) 2016; 6
Alzheimer's (b0015) 2015; 11
Fuller, Steele, Munch (b0110) 2010; 690
Leuba, Walzer, Vernay, Carnal, Kraftsik, Piotton, Marin, Bouras, Savioz (b0140) 2008; 30
Kayed, Lasagna-Reeves (b0130) 2013; 33
Qosa, Abuasal, Romero, Weksler, Couraud, Keller, Kaddoumi (b0200) 2014; 79
Wahrle, Jiang, Parsadanian, Legleiter, Han, Fryer, Kowalewski, Holtzman (b0260) 2004; 279
Abuznait, Qosa, Busnena, El Sayed, Kaddoumi (b0010) 2013; 4
Belanger, Magistretti (b0045) 2009; 11
Benarroch (b0055) 2005; 80
Busche, Konnerth (b0075) 2016
Perez, Carrero, Gonzalo, Arevalo-Serrano, Sanz-Anquela, Ortega, Rodriguez, Gonzalo-Ruiz (b0190) 2010; 223
Esparza, Wildburger, Jiang, Gangolli, Cairns, Bateman, Brody (b0095) 2016; 6
Batarseh, Duong, Mousa, Al Rihani, Elfakhri, Kaddoumi (b0030) 2016; 17
Bell, Zlokovic (b0050) 2009; 118
Auderset, Cullen, Young (b0025) 2016; 11
Perego, Vanoni, Bossi, Massari, Basudev, Longhi, Pietrini (b0185) 2000; 75
Jung, An, Hong, Kim, Mook-Jung (b0125) 2012; 32
Nielsen (10.1016/j.neuroscience.2017.03.059_b0175) 2010; 58
Perego (10.1016/j.neuroscience.2017.03.059_b0185) 2000; 75
Jung (10.1016/j.neuroscience.2017.03.059_b0125) 2012; 32
Pitt (10.1016/j.neuroscience.2017.03.059_b0195) 2009; 240
Siow (10.1016/j.neuroscience.2017.03.059_b9000) 2005; 157–158
Fernandes (10.1016/j.neuroscience.2017.03.059_b0105) 2017; 39
Glenner (10.1016/j.neuroscience.2017.03.059_b0115) 1984; 122
Li (10.1016/j.neuroscience.2017.03.059_b0145) 2011; 8
Murphy (10.1016/j.neuroscience.2017.03.059_b0165) 2010; 19
Lasagna-Reeves (10.1016/j.neuroscience.2017.03.059_b0135) 2011; 286
Wahrle (10.1016/j.neuroscience.2017.03.059_b0260) 2004; 279
Beauchamp (10.1016/j.neuroscience.2017.03.059_b0035) 2005; 437
Alzheimer's (10.1016/j.neuroscience.2017.03.059_b0015) 2015; 11
Scotece (10.1016/j.neuroscience.2017.03.059_b0225) 2012; 91
Tu (10.1016/j.neuroscience.2017.03.059_b0255) 2014; 9
Leuba (10.1016/j.neuroscience.2017.03.059_b0140) 2008; 30
Benarroch (10.1016/j.neuroscience.2017.03.059_b0060) 2014; 82
Qosa (10.1016/j.neuroscience.2017.03.059_b0205) 2015; 6
Feng (10.1016/j.neuroscience.2017.03.059_b0100) 2014; 7
Parkinson (10.1016/j.neuroscience.2017.03.059_b0180) 2014; 15
Rimmele (10.1016/j.neuroscience.2017.03.059_b0210) 2016; 98
Greber (10.1016/j.neuroscience.2017.03.059_b0120) 1999; 20
Sakono (10.1016/j.neuroscience.2017.03.059_b0215) 2010; 277
Bell (10.1016/j.neuroscience.2017.03.059_b0050) 2009; 118
Qosa (10.1016/j.neuroscience.2017.03.059_b0200) 2014; 79
Biedler (10.1016/j.neuroscience.2017.03.059_b0065) 1978; 38
Perez (10.1016/j.neuroscience.2017.03.059_b0190) 2010; 223
Sengupta (10.1016/j.neuroscience.2017.03.059_b0240) 2016; 6
Beglopoulos (10.1016/j.neuroscience.2017.03.059_b0040) 2016; 7
Narayan (10.1016/j.neuroscience.2017.03.059_b0170) 2014; 53
Benarroch (10.1016/j.neuroscience.2017.03.059_b0055) 2005; 80
Fuller (10.1016/j.neuroscience.2017.03.059_b0110) 2010; 690
Wyss-Coray (10.1016/j.neuroscience.2017.03.059_b0265) 2003; 9
Belanger (10.1016/j.neuroscience.2017.03.059_b0045) 2009; 11
Abuznait (10.1016/j.neuroscience.2017.03.059_b0010) 2013; 4
Brown (10.1016/j.neuroscience.2017.03.059_b0070) 2014; 26
Scimemi (10.1016/j.neuroscience.2017.03.059_b0220) 2013; 33
Cobos (10.1016/j.neuroscience.2017.03.059_b0080) 2007; 102
Son (10.1016/j.neuroscience.2017.03.059_b0245) 2016; 12
Antonucci (10.1016/j.neuroscience.2017.03.059_b0020) 2016; 8
Busche (10.1016/j.neuroscience.2017.03.059_b0075) 2016
Auderset (10.1016/j.neuroscience.2017.03.059_b0025) 2016; 11
Kayed (10.1016/j.neuroscience.2017.03.059_b0130) 2013; 33
Abbott (10.1016/j.neuroscience.2017.03.059_b0005) 2002; 200
Danbolt (10.1016/j.neuroscience.2017.03.059_b0085) 2016; 98
Batarseh (10.1016/j.neuroscience.2017.03.059_b0030) 2016; 17
Esparza (10.1016/j.neuroscience.2017.03.059_b0095) 2016; 6
Masters (10.1016/j.neuroscience.2017.03.059_b0155) 1985; 82
Selkoe (10.1016/j.neuroscience.2017.03.059_b0230) 2001; 81
Selkoe (10.1016/j.neuroscience.2017.03.059_b0235) 2008; 192
Li (10.1016/j.neuroscience.2017.03.059_b0150) 2009; 110
Spuch (10.1016/j.neuroscience.2017.03.059_b0250) 2012; 3
References_xml – volume: 4
  start-page: 973
  year: 2013
  end-page: 982
  ident: b0010
  article-title: Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies
  publication-title: ACS Chem Neurosci
  contributor:
    fullname: Kaddoumi
– volume: 32
  start-page: 3081
  year: 2012
  end-page: 3087
  ident: b0125
  article-title: Astrocyte-originated ATP protects Abeta(1–42)-induced impairment of synaptic plasticity
  publication-title: J Neurosci
  contributor:
    fullname: Mook-Jung
– volume: 30
  start-page: 408
  year: 2008
  end-page: 419
  ident: b0140
  article-title: Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction
  publication-title: Neurobiol Dis
  contributor:
    fullname: Savioz
– volume: 11
  start-page: 281
  year: 2009
  end-page: 295
  ident: b0045
  article-title: The role of astroglia in neuroprotection
  publication-title: Dial Clin Neurosci
  contributor:
    fullname: Magistretti
– volume: 192
  start-page: 106
  year: 2008
  end-page: 113
  ident: b0235
  article-title: Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior
  publication-title: Behav Brain Res
  contributor:
    fullname: Selkoe
– volume: 38
  start-page: 3751
  year: 1978
  end-page: 3757
  ident: b0065
  article-title: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones
  publication-title: Cancer Res
  contributor:
    fullname: Freedman
– volume: 17
  start-page: 338
  year: 2016
  ident: b0030
  article-title: Amyloid-beta and astrocytes interplay in amyloid-beta related disorders
  publication-title: Int J Mol Sci
  contributor:
    fullname: Kaddoumi
– volume: 53
  start-page: 2442
  year: 2014
  end-page: 2453
  ident: b0170
  article-title: Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage
  publication-title: Biochemistry
  contributor:
    fullname: Klenerman
– volume: 223
  start-page: 410
  year: 2010
  end-page: 421
  ident: b0190
  article-title: Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain
  publication-title: Exp Neurol
  contributor:
    fullname: Gonzalo-Ruiz
– volume: 3
  start-page: 269
  year: 2012
  ident: b0250
  article-title: LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease
  publication-title: Front Physiol
  contributor:
    fullname: Navarro
– volume: 200
  start-page: 629
  year: 2002
  end-page: 638
  ident: b0005
  article-title: Astrocyte-endothelial interactions and blood–brain barrier permeability
  publication-title: J Anat
  contributor:
    fullname: Abbott
– volume: 11
  start-page: 332
  year: 2015
  end-page: 384
  ident: b0015
  article-title: 2015 Alzheimer's disease facts and figures
  publication-title: Alzheimer's Dement
  contributor:
    fullname: Alzheimer's
– volume: 11
  start-page: e0155878
  year: 2016
  ident: b0025
  article-title: Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system
  publication-title: PLoS One
  contributor:
    fullname: Young
– volume: 110
  start-page: 1339
  year: 2009
  end-page: 1351
  ident: b0150
  article-title: Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
  publication-title: J Neurochem
  contributor:
    fullname: Lee
– volume: 240
  start-page: 189
  year: 2009
  end-page: 197
  ident: b0195
  article-title: Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
  publication-title: Toxicol Appl Pharmacol
  contributor:
    fullname: Klein
– volume: 33
  start-page: 5312
  year: 2013
  end-page: 5318
  ident: b0220
  article-title: Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1
  publication-title: J Neurosci
  contributor:
    fullname: Cook
– volume: 102
  start-page: 812
  year: 2007
  end-page: 825
  ident: b0080
  article-title: Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells
  publication-title: J Neurochem
  contributor:
    fullname: Baeyens
– volume: 75
  start-page: 1076
  year: 2000
  end-page: 1084
  ident: b0185
  article-title: The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures
  publication-title: J Neurochem
  contributor:
    fullname: Pietrini
– volume: 98
  start-page: 19
  year: 2016
  end-page: 28
  ident: b0210
  article-title: GLT-1: the elusive presynaptic glutamate transporter
  publication-title: Neurochem Int
  contributor:
    fullname: Rosenberg
– volume: 98
  start-page: 29
  year: 2016
  end-page: 45
  ident: b0085
  article-title: Neuronal vs glial glutamate uptake: Resolving the conundrum
  publication-title: Neurochem Int
  contributor:
    fullname: Zhou
– volume: 8
  start-page: 67
  year: 2011
  end-page: 80
  ident: b0145
  article-title: Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease
  publication-title: Curr Alzheimer Res
  contributor:
    fullname: Yu
– volume: 118
  start-page: 103
  year: 2009
  end-page: 113
  ident: b0050
  article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease
  publication-title: Acta Neuropathol
  contributor:
    fullname: Zlokovic
– volume: 8
  start-page: 7
  year: 2016
  ident: b0020
  article-title: SNAP-25, a known presynaptic protein with emerging postsynaptic functions
  publication-title: Front Syn Neurosci
  contributor:
    fullname: Matteoli
– volume: 9
  start-page: 48
  year: 2014
  ident: b0255
  article-title: Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease
  publication-title: Mol Neurodegeneration
  contributor:
    fullname: Xu
– volume: 7
  start-page: 549
  year: 2014
  end-page: 557
  ident: b0100
  article-title: Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins
  publication-title: Int J Clin Exp Med
  contributor:
    fullname: Du
– volume: 39
  start-page: 84
  year: 2017
  end-page: 92
  ident: b0105
  article-title: High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells
  publication-title: Toxicol In Vitro
  contributor:
    fullname: Santos
– volume: 122
  start-page: 1131
  year: 1984
  end-page: 1135
  ident: b0115
  article-title: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Wong
– volume: 79
  start-page: 668
  year: 2014
  end-page: 678
  ident: b0200
  article-title: Differences in amyloid-beta clearance across mouse and human blood–brain barrier models: kinetic analysis and mechanistic modeling
  publication-title: Neuropharmacology
  contributor:
    fullname: Kaddoumi
– volume: 437
  start-page: 45
  year: 2005
  end-page: 46
  ident: b0035
  article-title: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil
  publication-title: Nature
  contributor:
    fullname: Breslin
– volume: 277
  start-page: 1348
  year: 2010
  end-page: 1358
  ident: b0215
  article-title: Amyloid oligomers: formation and toxicity of Abeta oligomers
  publication-title: FEBS J
  contributor:
    fullname: Zako
– volume: 82
  start-page: 4245
  year: 1985
  end-page: 4249
  ident: b0155
  article-title: Amyloid plaque core protein in Alzheimer disease and Down syndrome
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Beyreuther
– volume: 286
  start-page: 22122
  year: 2011
  end-page: 22130
  ident: b0135
  article-title: Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain
  publication-title: J Biol Chem
  contributor:
    fullname: Kayed
– volume: 6
  start-page: 1849
  year: 2015
  end-page: 1859
  ident: b0205
  article-title: Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model
  publication-title: ACS Chem Neurosci
  contributor:
    fullname: Kaddoumi
– volume: 279
  start-page: 40987
  year: 2004
  end-page: 40993
  ident: b0260
  article-title: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
  publication-title: J Biol Chem
  contributor:
    fullname: Holtzman
– volume: 157–158
  start-page: 423
  year: 2005
  end-page: 426
  ident: b9000
  article-title: ATP induces the post-synaptic gene expression in neuron-neuron synapses: Transcriptional regulation of AChE catalytic subunit
  publication-title: Chem-biol interact
  contributor:
    fullname: Tsim
– volume: 91
  start-page: 1229
  year: 2012
  end-page: 1235
  ident: b0225
  article-title: Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1alpha and IL-6 in J774 macrophages and in ATDC5 chondrocytes
  publication-title: Life Sci
  contributor:
    fullname: Gualillo
– volume: 15
  start-page: 12323
  year: 2014
  end-page: 12334
  ident: b0180
  article-title: Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease
  publication-title: Int J Mol Sci
  contributor:
    fullname: Keast
– volume: 9
  start-page: 453
  year: 2003
  end-page: 457
  ident: b0265
  article-title: Adult mouse astrocytes degrade amyloid-beta in vitro and in situ
  publication-title: Nat Med
  contributor:
    fullname: Husemann
– volume: 7
  start-page: 11761
  year: 2016
  ident: b0040
  article-title: Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice
  publication-title: Nat Commun
  contributor:
    fullname: Morris
– volume: 26
  start-page: 230
  year: 2014
  end-page: 239
  ident: b0070
  article-title: PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease
  publication-title: Neurotox Res
  contributor:
    fullname: Tizabi
– volume: 12
  start-page: 784
  year: 2016
  end-page: 800
  ident: b0245
  article-title: Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
  publication-title: Autophagy
  contributor:
    fullname: Mook-Jung
– volume: 81
  start-page: 741
  year: 2001
  end-page: 766
  ident: b0230
  article-title: Alzheimer's disease: genes, proteins, and therapy
  publication-title: Physiol Rev
  contributor:
    fullname: Selkoe
– volume: 690
  start-page: 40
  year: 2010
  end-page: 49
  ident: b0110
  article-title: Activated astroglia during chronic inflammation in Alzheimer's disease–do they neglect their neurosupportive roles?
  publication-title: Mutat Res
  contributor:
    fullname: Munch
– volume: 80
  start-page: 1326
  year: 2005
  end-page: 1338
  ident: b0055
  article-title: Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system
  publication-title: Mayo Clin Proc
  contributor:
    fullname: Benarroch
– start-page: 371
  year: 2016
  ident: b0075
  article-title: Impairments of neural circuit function in Alzheimer's disease
  publication-title: Philo Trans R Soc Lond Ser B
  contributor:
    fullname: Konnerth
– volume: 20
  start-page: 928
  year: 1999
  end-page: 934
  ident: b0120
  article-title: Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
  publication-title: Electrophoresis
  contributor:
    fullname: Fountoulakis
– volume: 6
  start-page: 38187
  year: 2016
  ident: b0095
  article-title: Soluble amyloid-beta aggregates from human Alzheimer's disease brains
  publication-title: Sci Rep
  contributor:
    fullname: Brody
– volume: 33
  start-page: S67
  year: 2013
  end-page: 78
  ident: b0130
  article-title: Molecular mechanisms of amyloid oligomers toxicity
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Lasagna-Reeves
– volume: 19
  start-page: 311
  year: 2010
  end-page: 323
  ident: b0165
  article-title: Alzheimer's disease and the amyloid-beta peptide
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: LeVine
– volume: 58
  start-page: 1235
  year: 2010
  end-page: 1246
  ident: b0175
  article-title: Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins
  publication-title: Glia
  contributor:
    fullname: Veerhuis
– volume: 6
  start-page: 42
  year: 2016
  end-page: 49
  ident: b0240
  article-title: The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy
  publication-title: EBioMedicine
  contributor:
    fullname: Kayed
– volume: 82
  start-page: 1374
  year: 2014
  end-page: 1379
  ident: b0060
  article-title: Brain glucose transporters: implications for neurologic disease
  publication-title: Neurology
  contributor:
    fullname: Benarroch
– volume: 15
  start-page: 12323
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0180
  article-title: Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms150712323
  contributor:
    fullname: Parkinson
– volume: 6
  start-page: 38187
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0095
  article-title: Soluble amyloid-beta aggregates from human Alzheimer's disease brains
  publication-title: Sci Rep
  doi: 10.1038/srep38187
  contributor:
    fullname: Esparza
– volume: 9
  start-page: 48
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0255
  article-title: Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease
  publication-title: Mol Neurodegeneration
  doi: 10.1186/1750-1326-9-48
  contributor:
    fullname: Tu
– volume: 11
  start-page: 332
  year: 2015
  ident: 10.1016/j.neuroscience.2017.03.059_b0015
  article-title: 2015 Alzheimer's disease facts and figures
  publication-title: Alzheimer's Dement
  doi: 10.1016/j.jalz.2015.02.003
  contributor:
    fullname: Alzheimer's
– volume: 690
  start-page: 40
  year: 2010
  ident: 10.1016/j.neuroscience.2017.03.059_b0110
  article-title: Activated astroglia during chronic inflammation in Alzheimer's disease–do they neglect their neurosupportive roles?
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2009.08.016
  contributor:
    fullname: Fuller
– volume: 33
  start-page: 5312
  year: 2013
  ident: 10.1016/j.neuroscience.2017.03.059_b0220
  article-title: Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5274-12.2013
  contributor:
    fullname: Scimemi
– volume: 20
  start-page: 928
  year: 1999
  ident: 10.1016/j.neuroscience.2017.03.059_b0120
  article-title: Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
  publication-title: Electrophoresis
  doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z
  contributor:
    fullname: Greber
– volume: 6
  start-page: 42
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0240
  article-title: The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.03.035
  contributor:
    fullname: Sengupta
– volume: 7
  start-page: 549
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0100
  article-title: Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins
  publication-title: Int J Clin Exp Med
  contributor:
    fullname: Feng
– volume: 30
  start-page: 408
  year: 2008
  ident: 10.1016/j.neuroscience.2017.03.059_b0140
  article-title: Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2008.02.012
  contributor:
    fullname: Leuba
– volume: 223
  start-page: 410
  year: 2010
  ident: 10.1016/j.neuroscience.2017.03.059_b0190
  article-title: Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2009.10.013
  contributor:
    fullname: Perez
– volume: 58
  start-page: 1235
  year: 2010
  ident: 10.1016/j.neuroscience.2017.03.059_b0175
  article-title: Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins
  publication-title: Glia
  doi: 10.1002/glia.21004
  contributor:
    fullname: Nielsen
– volume: 75
  start-page: 1076
  year: 2000
  ident: 10.1016/j.neuroscience.2017.03.059_b0185
  article-title: The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2000.0751076.x
  contributor:
    fullname: Perego
– volume: 8
  start-page: 7
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0020
  article-title: SNAP-25, a known presynaptic protein with emerging postsynaptic functions
  publication-title: Front Syn Neurosci
  doi: 10.3389/fnsyn.2016.00007
  contributor:
    fullname: Antonucci
– volume: 4
  start-page: 973
  year: 2013
  ident: 10.1016/j.neuroscience.2017.03.059_b0010
  article-title: Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies
  publication-title: ACS Chem Neurosci
  doi: 10.1021/cn400024q
  contributor:
    fullname: Abuznait
– volume: 98
  start-page: 29
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0085
  article-title: Neuronal vs glial glutamate uptake: Resolving the conundrum
  publication-title: Neurochem Int
  doi: 10.1016/j.neuint.2016.05.009
  contributor:
    fullname: Danbolt
– volume: 17
  start-page: 338
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0030
  article-title: Amyloid-beta and astrocytes interplay in amyloid-beta related disorders
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17030338
  contributor:
    fullname: Batarseh
– volume: 32
  start-page: 3081
  year: 2012
  ident: 10.1016/j.neuroscience.2017.03.059_b0125
  article-title: Astrocyte-originated ATP protects Abeta(1–42)-induced impairment of synaptic plasticity
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.6357-11.2012
  contributor:
    fullname: Jung
– volume: 118
  start-page: 103
  year: 2009
  ident: 10.1016/j.neuroscience.2017.03.059_b0050
  article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-009-0522-3
  contributor:
    fullname: Bell
– volume: 7
  start-page: 11761
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0040
  article-title: Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice
  publication-title: Nat Commun
  doi: 10.1038/ncomms11761
  contributor:
    fullname: Beglopoulos
– volume: 200
  start-page: 629
  year: 2002
  ident: 10.1016/j.neuroscience.2017.03.059_b0005
  article-title: Astrocyte-endothelial interactions and blood–brain barrier permeability
  publication-title: J Anat
  doi: 10.1046/j.1469-7580.2002.00064.x
  contributor:
    fullname: Abbott
– volume: 110
  start-page: 1339
  year: 2009
  ident: 10.1016/j.neuroscience.2017.03.059_b0150
  article-title: Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2009.06224.x
  contributor:
    fullname: Li
– volume: 279
  start-page: 40987
  year: 2004
  ident: 10.1016/j.neuroscience.2017.03.059_b0260
  article-title: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M407963200
  contributor:
    fullname: Wahrle
– volume: 53
  start-page: 2442
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0170
  article-title: Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage
  publication-title: Biochemistry
  doi: 10.1021/bi401606f
  contributor:
    fullname: Narayan
– volume: 91
  start-page: 1229
  year: 2012
  ident: 10.1016/j.neuroscience.2017.03.059_b0225
  article-title: Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1alpha and IL-6 in J774 macrophages and in ATDC5 chondrocytes
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2012.09.012
  contributor:
    fullname: Scotece
– volume: 437
  start-page: 45
  year: 2005
  ident: 10.1016/j.neuroscience.2017.03.059_b0035
  article-title: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil
  publication-title: Nature
  doi: 10.1038/437045a
  contributor:
    fullname: Beauchamp
– volume: 82
  start-page: 4245
  year: 1985
  ident: 10.1016/j.neuroscience.2017.03.059_b0155
  article-title: Amyloid plaque core protein in Alzheimer disease and Down syndrome
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.82.12.4245
  contributor:
    fullname: Masters
– volume: 19
  start-page: 311
  year: 2010
  ident: 10.1016/j.neuroscience.2017.03.059_b0165
  article-title: Alzheimer's disease and the amyloid-beta peptide
  publication-title: J Alzheimer's Dis
  doi: 10.3233/JAD-2010-1221
  contributor:
    fullname: Murphy
– volume: 286
  start-page: 22122
  year: 2011
  ident: 10.1016/j.neuroscience.2017.03.059_b0135
  article-title: Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.236257
  contributor:
    fullname: Lasagna-Reeves
– volume: 80
  start-page: 1326
  year: 2005
  ident: 10.1016/j.neuroscience.2017.03.059_b0055
  article-title: Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system
  publication-title: Mayo Clin Proc
  doi: 10.4065/80.10.1326
  contributor:
    fullname: Benarroch
– volume: 157–158
  start-page: 423
  year: 2005
  ident: 10.1016/j.neuroscience.2017.03.059_b9000
  article-title: ATP induces the post-synaptic gene expression in neuron-neuron synapses: Transcriptional regulation of AChE catalytic subunit
  publication-title: Chem-biol interact
  doi: 10.1016/j.cbi.2005.10.088
  contributor:
    fullname: Siow
– volume: 8
  start-page: 67
  year: 2011
  ident: 10.1016/j.neuroscience.2017.03.059_b0145
  article-title: Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease
  publication-title: Curr Alzheimer Res
  doi: 10.2174/156720511794604543
  contributor:
    fullname: Li
– volume: 277
  start-page: 1348
  year: 2010
  ident: 10.1016/j.neuroscience.2017.03.059_b0215
  article-title: Amyloid oligomers: formation and toxicity of Abeta oligomers
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2010.07568.x
  contributor:
    fullname: Sakono
– volume: 192
  start-page: 106
  year: 2008
  ident: 10.1016/j.neuroscience.2017.03.059_b0235
  article-title: Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2008.02.016
  contributor:
    fullname: Selkoe
– volume: 11
  start-page: 281
  year: 2009
  ident: 10.1016/j.neuroscience.2017.03.059_b0045
  article-title: The role of astroglia in neuroprotection
  publication-title: Dial Clin Neurosci
  doi: 10.31887/DCNS.2009.11.3/mbelanger
  contributor:
    fullname: Belanger
– volume: 81
  start-page: 741
  year: 2001
  ident: 10.1016/j.neuroscience.2017.03.059_b0230
  article-title: Alzheimer's disease: genes, proteins, and therapy
  publication-title: Physiol Rev
  doi: 10.1152/physrev.2001.81.2.741
  contributor:
    fullname: Selkoe
– volume: 11
  start-page: e0155878
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0025
  article-title: Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0155878
  contributor:
    fullname: Auderset
– volume: 26
  start-page: 230
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0070
  article-title: PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease
  publication-title: Neurotox Res
  doi: 10.1007/s12640-014-9468-x
  contributor:
    fullname: Brown
– volume: 82
  start-page: 1374
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0060
  article-title: Brain glucose transporters: implications for neurologic disease
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000328
  contributor:
    fullname: Benarroch
– volume: 240
  start-page: 189
  year: 2009
  ident: 10.1016/j.neuroscience.2017.03.059_b0195
  article-title: Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2009.07.018
  contributor:
    fullname: Pitt
– volume: 102
  start-page: 812
  year: 2007
  ident: 10.1016/j.neuroscience.2017.03.059_b0080
  article-title: Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2007.04533.x
  contributor:
    fullname: Cobos
– volume: 39
  start-page: 84
  year: 2017
  ident: 10.1016/j.neuroscience.2017.03.059_b0105
  article-title: High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells
  publication-title: Toxicol In Vitro
  doi: 10.1016/j.tiv.2016.12.003
  contributor:
    fullname: Fernandes
– volume: 12
  start-page: 784
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0245
  article-title: Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
  publication-title: Autophagy
  doi: 10.1080/15548627.2016.1159375
  contributor:
    fullname: Son
– start-page: 371
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0075
  article-title: Impairments of neural circuit function in Alzheimer's disease
  publication-title: Philo Trans R Soc Lond Ser B
  contributor:
    fullname: Busche
– volume: 79
  start-page: 668
  year: 2014
  ident: 10.1016/j.neuroscience.2017.03.059_b0200
  article-title: Differences in amyloid-beta clearance across mouse and human blood–brain barrier models: kinetic analysis and mechanistic modeling
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2014.01.023
  contributor:
    fullname: Qosa
– volume: 9
  start-page: 453
  year: 2003
  ident: 10.1016/j.neuroscience.2017.03.059_b0265
  article-title: Adult mouse astrocytes degrade amyloid-beta in vitro and in situ
  publication-title: Nat Med
  doi: 10.1038/nm838
  contributor:
    fullname: Wyss-Coray
– volume: 33
  start-page: S67
  issue: Suppl 1
  year: 2013
  ident: 10.1016/j.neuroscience.2017.03.059_b0130
  article-title: Molecular mechanisms of amyloid oligomers toxicity
  publication-title: J Alzheimer's Dis
  contributor:
    fullname: Kayed
– volume: 38
  start-page: 3751
  year: 1978
  ident: 10.1016/j.neuroscience.2017.03.059_b0065
  article-title: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones
  publication-title: Cancer Res
  contributor:
    fullname: Biedler
– volume: 6
  start-page: 1849
  year: 2015
  ident: 10.1016/j.neuroscience.2017.03.059_b0205
  article-title: Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model
  publication-title: ACS Chem Neurosci
  doi: 10.1021/acschemneuro.5b00190
  contributor:
    fullname: Qosa
– volume: 3
  start-page: 269
  year: 2012
  ident: 10.1016/j.neuroscience.2017.03.059_b0250
  article-title: LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00269
  contributor:
    fullname: Spuch
– volume: 122
  start-page: 1131
  year: 1984
  ident: 10.1016/j.neuroscience.2017.03.059_b0115
  article-title: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(84)91209-9
  contributor:
    fullname: Glenner
– volume: 98
  start-page: 19
  year: 2016
  ident: 10.1016/j.neuroscience.2017.03.059_b0210
  article-title: GLT-1: the elusive presynaptic glutamate transporter
  publication-title: Neurochem Int
  doi: 10.1016/j.neuint.2016.04.010
  contributor:
    fullname: Rimmele
SSID ssj0000543
Score 2.4894538
Snippet Highlights • Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in-vitro. • Oleocanthal reduced astrocytes activation and...
•Oleocanthal rectified Aβo-induced pathological changes in astrocytes and neurons in vitro.•Oleocanthal reduced astrocyte activation and inflammation...
Extra-virgin olive oil (EVOO) has several health promoting effects. Evidence have shown that EVOO attenuates the pathology of amyloid-β (Aβ) and improves...
SourceID pubmedcentral
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 204
SubjectTerms Aldehydes - pharmacology
Amyloid beta-Peptides - toxicity
Amyloid beta-Protein Precursor - genetics
Amyloid beta-Protein Precursor - metabolism
amyloid-β
Anti-Inflammatory Agents - pharmacology
astrocytes
Astrocytes - drug effects
Cell Line, Tumor
Disks Large Homolog 4 Protein - metabolism
Dose-Response Relationship, Drug
Glutamate Plasma Membrane Transport Proteins - metabolism
Humans
Interleukin-6 - metabolism
Nerve Tissue Proteins - metabolism
neuroinflammation
Neurology
neurons
Neurons - drug effects
oleocanthal
Phenols - pharmacology
Synaptosomal-Associated Protein 25 - metabolism
Time Factors
Transfection
Title Oleocanthal Ameliorates Amyloid-β Oligomers Toxicity on Astrocytes and Neuronal Cells: In-vitro Studies
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0306452217302348
https://dx.doi.org/10.1016/j.neuroscience.2017.03.059
https://www.ncbi.nlm.nih.gov/pubmed/28392295
https://pubmed.ncbi.nlm.nih.gov/PMC5504696
Volume 352
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwELYQvfSCoJSy_UE-VNzCJrGTrCv1sEJFSxFwaJG4WY5_IHQ3QU2oyqXqa_Q1-iB9iD5JZ5xk2RWHInFKnIxlxzO2Pzsznwl5G-nUMeS3U8aagBubBLmxKnCaCyW4y6MQo5GPT9LJGf94npyvkP0-FgbdKruxvx3T_WjdPRl2rTm8LorhJ0S7yAceZXjwDceAX0hi59z7cefmAZCkPSIZVs4o3ROPeh-vBc5IpMyMMk94iryl_5mklh0oF2akg3Wy1kFJOm5ru0FWbPmMbI5LWEbPbuku9c6dftd8k3w5ndoKW_EScqiZnWJkPqBMuIcVe2GCP79pNS0uKtzG_vvzF22q74UGhE6rkqq6gWnu1ouXhvrPwZJx079-Rw9L-q0ACVq3PonPydnBh8_7k6A7ZyHQCY-bYIQgTbs4cU6IJB8xlnKljQ0VkvWpTCeAU5LchSzOspxDn7VRagBpabgwbdgWWS2r0m4TCu3tUm0BV-If1UzkIlJaOKtCo0cjkQ4I6xtWXrd0GrL3M7uSi-qQqA4ZMgnqGJCs14HsA0ZhiLN1199qGck6lqG8ZxMD8n6ec8msJMwYDyr5RavpeW1jRJSxSKBOSzYwF0C-7uU3ZXHpebthMchTkb58ZJ1ekaeY8v5q7DVZbb7e2DeAjJp8x5v-DnkyPjyanPwDw8YVRA
link.rule.ids 230,315,786,790,891,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZKOcAFUQp0CwUfELewSez8GIlDVbXaQlsOtFJvluOfNmWbVE1A9FL1NXgNHoSH4Ek64yTLrjiAxClRPFacGf98dma-IeRVpFPHkN9OGWsCbmwSFMaqwGkulOCuiEKMRt4_SCdH_P1xcrxEtoZYGHSr7Of-bk73s3X_ZNxrc3xRluNPiHaRDzzKMPENz--QuwjnMX_Dm-vffh6ASbocybB1RvGBedQ7ec2RRiJnZpR5xlMkLv3LKrXoQTm3JO08JA96LEk3u-aukCVbPSKrmxXso8-v6GvqvTv9sfkq-fxxamtU4ynUUOd2iqH5ADPhHrbspQl-_qD1tDyp8Rz718132tbfSg0QndYVVU0L69yVF68M9Z-Db8ZT_-Yt3a3o1xIkaNM5JT4mRzvbh1uToE-0EOiEx22QI0rTLk6cEyIpcsZSrrSxoUK2PpXpBIBKUriQxVlWcBi0NkoNQC0NF6YNe0KWq7qya4SCvl2qLQBL_KWaiUJESgtnVWh0not0RNigWHnR8WnIwdHsTM6bQ6I5ZMgkmGNEssEGcogYhTnONv2Aa2Qkm1iG8o9OMSLvZjUX-pWEJeOf3vy0s_SstTFCylgk0KaFPjATQMLuxZKqPPXE3bAb5KlI1_-zTS_Jvcnh_p7c2z348IzcxxLvvMaek-X28ovdAJjUFi_8MLgF-CsW1g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oleocanthal+ameliorates+amyloid-%CE%B2+oligomers%27+toxicity+on+astrocytes+and+neuronal+cells%3A+In+vitro+studies&rft.jtitle=Neuroscience&rft.au=Batarseh%2C+Yazan+S&rft.au=Mohamed%2C+Loqman+A&rft.au=Al+Rihani%2C+Sweilem+B&rft.au=Mousa%2C+Youssef+M&rft.date=2017-06-03&rft.eissn=1873-7544&rft.volume=352&rft.spage=204&rft_id=info:doi/10.1016%2Fj.neuroscience.2017.03.059&rft_id=info%3Apmid%2F28392295&rft.externalDocID=28392295
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-4522&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-4522&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-4522&client=summon